Another Surging Pharma Stock to Watch Right Now
LillyLilly(US:LLY) Schaeffers Investment Research·2025-10-01 17:53

Core Insights - Eli Lilly's stock is up 7.2% to $821.20 following the announcement of a 100% tariff on branded pharmaceutical products, but the company is exempt due to a $27 billion expansion in U.S. manufacturing [1] - The stock has reached its highest level since June and is on track for a fourth consecutive win, marking its best daily percentage gain since April, although it remains 7.1% lower year-over-year [2] - Eli Lilly options are popular among call traders, with a high put/call volume ratio of 1.85, indicating strong interest in bullish positions [3] Trading Activity - A significant volume of options trading has been observed, with 124,000 calls and 44,000 puts exchanged today, which is four times the average daily rate [4] - The most popular options are the 800- and 820-strike calls set to expire this Friday, indicating a bullish sentiment among traders [4] - The current Schaeffer's Volatility Index (SVI) of 31% suggests low volatility expectations, ranking in the low 17th percentile of its annual range, making options relatively inexpensive [5]